azd-5438
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2004 (NCT00088790)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cyclin-dependent kinaseINHIBITOR
Cyclin-dependent kinase inhibitor
Potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9 (CDK1 CDK2 and CDK9)
- Cyclin-dependent kinase 1 (CDK1) ↗
- Cyclin-dependent kinase 4 (CDK4) ↗
- Cyclin-dependent kinase 2 (CDK2) ↗
- Cyclin-dependent-like kinase 5 (CDK5) ↗
- Cyclin-dependent kinase 6 (CDK6) ↗
- Cyclin-dependent kinase 7 (CDK7) ↗
- Cyclin-dependent kinase 3 (CDK3) ↗
- Cyclin-dependent kinase 16 (CDK16) ↗
- Cyclin-dependent kinase 18 (CDK18) ↗
- Cyclin-dependent kinase 8 (CDK8) ↗
- Cyclin-dependent kinase 17 (CDK17) ↗
- Cyclin-dependent kinase 11B (CDK11B) ↗
- Cyclin-dependent kinase 15 (CDK15) ↗
- Cyclin-dependent kinase 19 (CDK19) ↗
- Cyclin-dependent kinase 14 (CDK14) ↗
- Cyclin-dependent kinase 9 (CDK9) ↗
- Cyclin-dependent kinase 10 (CDK10) ↗
- Cyclin-dependent kinase 13 (CDK13) ↗
- Cyclin-dependent kinase 20 (CDK20) ↗
- Cyclin-dependent kinase 12 (CDK12) ↗
- Cyclin-dependent kinase 6
- Cyclin-dependent kinase 9
- Cyclin-dependent kinase 2
- Cyclin-dependent kinase 1
- Cyclin-dependent kinase 3
- Cyclin-dependent kinase 7
- Cyclin-dependent kinase 4
- Cyclin-dependent kinase 5
- Serine/threonine-protein kinase PCTAIRE-1
- Serine/threonine-protein kinase PCTAIRE-3
- Cell division protein kinase 8
- PITSLRE serine/threonine-protein kinase CDC2L1
- Serine/threonine-protein kinase PFTAIRE-2
- Cell division cycle 2-like protein kinase 6
- Serine/threonine-protein kinase PFTAIRE-1
- Serine/threonine-protein kinase PCTAIRE-2
- Cyclin-dependent kinase 10
- Cyclin-dependent kinase 13
- Cyclin-dependent kinase 2 and 4 (CDK2 and CDK4)
- CDK2/CDK4
- Cyclin-dependent kinase 20
- Cyclin-dependent kinase 12
- Cyclin-dependent kinase 4/6
- Cyclin-dependent kinase 8/19
- CDK4/CDK9
- Cyclin-dependent kinase 12/13
- CDK4/CDK1
- Cyclin-dependent kinase 2/4/6
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C- Mol. weight
- 371.47 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL488436 ↗
Also known as
- azd5438
- azd5438
- azd-5438
- azd-5438
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00088790 | Phase 1 | Jul 1, 2004 | AstraZeneca |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 1 | 1 | 1 | 2004 |
1 organizations
Page 1 / 1